Zosano Pharma Corp SEC Filings

Filed On	Filing
19 Jul 2022	25-NSE
07 Jun 2022	Form 4: Matthews Christine, Chief Financial Officer Sold 82 shares ($58.2)
07 Jun 2022	Form 4: Lo Steven, Director Sold 442 shares ($314)
03 Jun 2022	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
02 Jun 2022	8-K: Termination of a Material Definitive Agreement; Bankruptcy or Receivership +1 more
18 May 2022	SCHEDULE 13G
18 May 2022	8-K: Departure/Election of Directors or Officers; Compensation
13 May 2022	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
13 May 2022	10-Q
05 May 2022	8-K: Departure/Election of Directors or Officers; Compensation
29 Apr 2022	10-K/A
29 Apr 2022	8-K: Other Events
11 Apr 2022	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +2 more
01 Apr 2022	Form 4: Matthews Christine, Chief Financial Officer Sold 8,116 shares ($1.71K)
01 Apr 2022	Form 4: Kellerman Donald J, VP, Clinical Dev & Med Affairs Sold 4,006 shares ($842)
01 Apr 2022	Form 4: Lo Steven, Director Sold 23,633 shares ($4.97K)
01 Apr 2022	S-8
17 Mar 2022	10-K
17 Mar 2022	8-K: Results of Operations and Financial Condition
25 Feb 2022	DEF 14A

Comments